is tirzepatide still on shortage list US judge sides with FDA's removal of Lilly's weight loss drug from Food and Drug Administration Reconfirms

Your BMI Puts You in the Treatment Range The FDA-approved criteria for prescription weight loss medication are straightforward: BMI of 30 or higher (classified as obesity), or BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, sleep apnea, or high cholesterol If your BMI is in this range, you meet the basic clinical threshold

Why is it different for each individual

Open talks with your doctor help you notice issues early and adjust the plan

Remember to always consult your doctor before changing or stopping a medication

Baseline characteristics and demographics were similar between DGs ( N =411)

Retatrutide's triple-agonist mechanism (GLP-1 + GIP + glucagon) produces diarrhea in approximately 34% of users at 12 mg, compared to roughly 30% for semaglutide at 2.4 mg